Pliant Therapeutics Inc (PLRX)
Healthcare
Biotechnology
1.00 $
+0.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Pliant Therapeutics Inc (PLRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -25 | -36 | -25 | -30 | -45 | -32 | -48 | -49 | -41 | -21 | -18 | -19 | -99 | |
| 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 1.5 | |
| 13 | 10 | 9.2 | 9.7 | 11 | 8.9 | 8.4 | 8.9 | 6.4 | 6.4 | 4.5 | 4.3 | 22 | |
| 13 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6.2 | -2.4 | 0.6 | 4.7 | -1.7 | 14 | -8.2 | -4.2 | -6.9 | -2.7 | -2.0 | -4.9 | -17 | |
| 0.6 | 0.1 | 0.1 | 1.5 | 1.3 | 0.9 | 0.2 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -23 | 38 | 32 | 60 | 11 | 31 | 39 | 69 | 35 | 28 | 1.8 | -4.1 | 61 | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -32 | – | – | |
| 0.2 | 0.7 | 0.2 | 22 | 0.7 | 0.5 | 0.1 | 0.5 | 0.0 | 0.1 | -32 | 0.1 | -32 | |
| -48 | 2.7 | 5.6 | 51 | -34 | -0.8 | -8.4 | 21 | -5.1 | 6.9 | -48 | -23 | -70 | |
| -25 | -36 | -25 | -32 | -47 | -33 | -48 | -49 | -41 | -21 | -18 | -19 | -99 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.